Pas­sage of FDA Mod­ern­iza­tion Act 2.0 clears the way to re­duce an­i­mal test­ing

While the fu­ture of drug de­vel­op­ment like­ly won’t be com­plete­ly an­i­mal-free, thanks to the pas­sage of the FDA Mod­ern­iza­tion Act 2.0, there may be less use of an­i­mals in sit­u­a­tions where they aren’t nec­es­sary.

The bill, which was added to the 2023 spend­ing pack­age that Pres­i­dent Joe Biden signed in­to law last week, doesn’t ban an­i­mal test­ing out­right, but it al­lows drug de­vel­op­ers to use al­ter­na­tive meth­ods to in­ves­ti­gate the safe­ty and ef­fec­tive­ness of a new drug.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER